schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.". .. . https://drbryanpwalsh.com/Treola-grandpa-of-Deglanville-from-Tijuana?Bischkene=220

..

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..

...

the state launched a review into the newspaper�s findings in late april.